September 10, 2018 / 11:41 PM / in 7 months

Generic drug group sues over New York opioid tax

The main trade group for generic drugmakers has sued New York to strike down a ban on opioid manufacturers passing on the costs of a newly adopted state tax intended to provide $100 million in annual funding for drug addiction treatment programs.

The Association for Accessible Medicines (AAM) filed a lawsuit in federal court in Manhattan on Friday challenging part of a law New York’s legislature passed in March when it approved a $168 billion state budget.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below